Blood Research

Cited by CrossRef (3)

  1. . Dasatinib/hydroxycarbamide/ruxolitinib. Reactions Weekly 2019;1750:106
    https://doi.org/10.1007/s40278-019-60970-4
  2. Yue Zhao, Deepti Reddi, Jenna McCracken, Natasha Iranzad, Cathrine Rehder, Jadee Neff, Endi Wang. Sequential Development of JAK2V617F Mutation and BCR-ABL1 Fusion in Individual Patients With Myeloproliferative Neoplasms. 2022;146:710
    https://doi.org/10.5858/arpa.2021-0096-OA
  3. Bohyun Kim, Kyu Taek Lee, Young Ahn Yoon, Young-Jin Choi. Clinical significance of myeloproliferative neoplasms with JAK2V617F mutations and major BCR-ABL1 translocations: a literature review with case presentation. Blood Res 2020;55:62
    https://doi.org/10.5045/br.2020.55.1.62
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd